Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karianne Schuurman

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Neuropathology and Experimental Neurology|January 16, 2014
Gender differences in multiple sclerosis: induction of estrogen signaling in male and progesterone signaling in female lesionsSabina Luchetti, Corbert G van Eden, Karianne Schuurman, et al.
International Journal of Cancer|September 7, 2019
IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancerDinja T Kruger, Xanthippi Alexi, Mark Opdam, et al.
Oncotarget|September 15, 2017
Loss of steroid hormone receptors is common in malignant pleural and peritoneal effusions of breast cancer patients treated with endocrine therapyWillemijne A M E Schrijver, Karianne Schuurman, Annelot van Rossum, et al.
Iscience|September 2, 2025
A 3D genome compendium of breast cancer progressionTeun van den Brand, Maria Donaldson Collier, Koen D Flach, et al.
Nucleic Acids Research|August 3, 2019
A CRISPR-Cas9 screen identifies essential CTCF anchor sites for estrogen receptor-driven breast cancer cell proliferationGozde Korkmaz, Zohar Manber, Rui Lopes, et al.
Life Science Alliance|January 9, 2019
Optimized ChIP-seq method facilitates transcription factor profiling in human tumorsAbhishek A Singh, Karianne Schuurman, Ekaterina Nevedomskaya, et al.
Molecular Oncology|July 5, 2018
FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcomeWillemijne Schrijver, Karianne Schuurman, Annelot van Rossum, et al.
Molecular Oncology|October 19, 2023
Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1-NDRG1 deregulationIsabel Mayayo-Peralta, Donna O Debets, Stefan Prekovic, et al.
Cell Chemical Biology|May 30, 2017
Proteasome Activation by Small MoleculesYves Leestemaker, Annemieke de Jong, Katharina F Witting, et al.
Genome Biology|May 9, 2025
Endometrial tumorigenesis involves epigenetic plasticity demarcating non-coding somatic mutations and 3D-genome alterationsSebastian Gregoricchio, Aleksandar Kojic, Marlous Hoogstraat, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Neuropathology and Experimental Neurology|January 16, 2014
Gender differences in multiple sclerosis: induction of estrogen signaling in male and progesterone signaling in female lesionsSabina Luchetti, Corbert G van Eden, Karianne Schuurman, et al.
International Journal of Cancer|September 7, 2019
IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancerDinja T Kruger, Xanthippi Alexi, Mark Opdam, et al.
Oncotarget|September 15, 2017
Loss of steroid hormone receptors is common in malignant pleural and peritoneal effusions of breast cancer patients treated with endocrine therapyWillemijne A M E Schrijver, Karianne Schuurman, Annelot van Rossum, et al.
Iscience|September 2, 2025
A 3D genome compendium of breast cancer progressionTeun van den Brand, Maria Donaldson Collier, Koen D Flach, et al.
Nucleic Acids Research|August 3, 2019
A CRISPR-Cas9 screen identifies essential CTCF anchor sites for estrogen receptor-driven breast cancer cell proliferationGozde Korkmaz, Zohar Manber, Rui Lopes, et al.
Life Science Alliance|January 9, 2019
Optimized ChIP-seq method facilitates transcription factor profiling in human tumorsAbhishek A Singh, Karianne Schuurman, Ekaterina Nevedomskaya, et al.
Molecular Oncology|July 5, 2018
FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcomeWillemijne Schrijver, Karianne Schuurman, Annelot van Rossum, et al.
Molecular Oncology|October 19, 2023
Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1-NDRG1 deregulationIsabel Mayayo-Peralta, Donna O Debets, Stefan Prekovic, et al.
Cell Chemical Biology|May 30, 2017
Proteasome Activation by Small MoleculesYves Leestemaker, Annemieke de Jong, Katharina F Witting, et al.
Genome Biology|May 9, 2025
Endometrial tumorigenesis involves epigenetic plasticity demarcating non-coding somatic mutations and 3D-genome alterationsSebastian Gregoricchio, Aleksandar Kojic, Marlous Hoogstraat, et al.
Pageof 3